Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
FLOMAX
Generic name / active ingredient
tamsulosin hydrochloride capsules
Dosage-form class
Tamsulosin hydrochloride immediate-release oral hard capsules, 0.4 mg. The 0.4 mg figure is the labelled amount per capsule and 100 is the number of capsules in the displayed brand bottle. The capsule must not be crushed, chewed or opened; these fields cannot become an individual dosing, restart, escalation, stopping or substitution plan.
Route
Oral
Record reviewed
2026-09-04

Copy from the pack in hand

Source-linked reading points

  • The label uses FLOMAX for signs and symptoms of benign prostatic hyperplasia and states that it is not indicated for hypertension. Urinary symptoms, dizziness or the words alpha blocker do not support self-switching or combining medicines.
  • The capsule should remain intact and must not be crushed, chewed or opened. The 0.4 mg figure is a labelled amount per capsule, not a website-derived rule for starting, restarting, increasing, replacing missed doses or stopping.
  • Dizziness on standing, hypotension or syncope may lead to falls. Older adults, people rising at night and those using other blood-pressure-affecting medicines should have the exact pack, symptoms and complete medicine list reviewed by a clinician or pharmacist.
  • Before cataract or glaucoma surgery, tell the eye-care team about current or past tamsulosin use. The label also says the benefit of stopping before surgery has not been established, so do not stop it from a web page.

Reviewed presentation examples — compare every field

  • Tamsulosin hydrochloride 0.4 mg per capsule; 100-capsule bottleNDC 0024-5837-01

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-09-04
Source record
4 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image